Cholesgen Enters Collaboration and Licensing Agreement with AstraZeneca for Hypercholesterolemia

This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint resea...

June 17, 2023 | Saturday | News
Astellas and Cullgen Forge Strategic Collaboration to Advance Targeted Protein Degraders

Under the terms of the agreement, the two companies aim to develop multiple targeted protein degraders by combining Cullgen's proprietary uSMITE™ tar...

June 15, 2023 | Thursday | News
Senju Pharma and Novaliq Sign License Agreement for NOV03 Dry Eye Treatment in Japan

"We are very pleased about the cooperation with Novaliq, a pioneer for groundbreaking non-aqueous eye drop technology. With regard to the unique properties...

June 14, 2023 | Wednesday | News
SomaLogic Partners with Citogen to Expand Authorized Site Program in Europe

SomaLogic, Inc., a leader in proteomics technology, announced today their collaboration with Citogen, the Longwood Group’s customer services and supp...

June 13, 2023 | Tuesday | News
Samsung Biologics and Pfizer announce strategic collaboration for long-term manufacturing of biosimilars portfolio

Under the terms of the new agreement, Samsung Biologics will provide Pfizer with additional capacity for large-scale manufacturing for a multi-product bios...

June 12, 2023 | Monday | News
Iktos and Curreio Announce Collaboration Agreement in New Drug Discovery

In this collaboration, Iktos’ de novo generative design technology in combination with Curreio’s state-of-the-art cryo-EM platform will be used...

June 09, 2023 | Friday | News
Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics

Clinically validated lipid nanoparticle (LNP) delivery technology will further strengthen Bayer’s gene therapy portfolio High potency ionizable li...

June 07, 2023 | Wednesday | News
Nordic Nanovector to Acquire Thor Medical, Advancing Cancer Radiopharmaceuticals

Gives Nordic Nanovector access to highly promising new technology that enables the development and production of radionuclides for radioimmunoconjugate-b...

June 07, 2023 | Wednesday | News
Sensydia Secures $3M NIH Grant to Advance AI-Based Cardiac Assessment Platform

Non-invasive cardiac diagnostic company Sensydia announced today that it was awarded a Fast-Track Small Business grant from the National Heart, Lung, and B...

June 06, 2023 | Tuesday | News
MEDiC Life Sciences Announces Collaboration with Bristol Myers Squibb on Tumor Target Discovery

“We are very excited that Bristol Myers Squibb selected MEDiC as a collaborator to advance its oncology discovery programs,” said Kyuho Han, Ph...

June 06, 2023 | Tuesday | News
Trethera Secures $2M Grant from National Cancer Institute for Biomarker Advancement in Phase 1 Trial

The grant will fund additional patient dosing studies to identify predictive biomarkers of activity and target engagement of TRE-515 in solid tumors. Treth...

May 31, 2023 | Wednesday | News
Roquette Announces Strategic Investment and Innovation Agreement with Beren Therapeutics P.B.C.

Beren is a vertically integrated biopharmaceutical company focused on addressing the world’s most significant health challenges. Roquette recognizes ...

May 24, 2023 | Wednesday | News
Next&Bio and CSI Singapore Sign MOU for Organoid Collaboration

 Next&Bio has teamed up with the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) to establish ...

May 19, 2023 | Friday | News
Alliance Pharma and Drug Development Solutions Are Now Resolian

“Resolian merges expertise from Alliance Pharma and Drug Development Solutions — two leading providers of bioanalysis and analytical sciences &...

May 19, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close